Thalidomide and cancer cachexia: Old problem, new hope?

Gut

Volumn 54, Issue 4, 2005, Pages 447-448

  Stroud, M ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; MEGESTROL ACETATE; THALIDOMIDE;

APPETITE DISORDER; BIRTH DEFECT; CACHEXIA; CANCER; CLINICAL TRIAL; HUMAN; PANCREAS CANCER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

ANGIOGENESIS INHIBITORS; CACHEXIA; HUMANS; NEOPLASMS; PANCREATIC NEOPLASMS; THALIDOMIDE;

EID: 15444381069     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.053330     Document Type: Review

References (19)

1. Palesty JA, Dudrick SJ. What we have learned about cachexia in gastrointestinal cancer. Dig Dis 2003;21:198-213.
2. Buzby GP, Mullen JP, Matthews DC. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980;139:160.
3. Bosaeus I, Daneryd P, Svanberg E, et al. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 2001;93:380-3.
4. Gibney E, Elia M, Jebb SA, et al. Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 1997;46:1412-17.
5. Jebb SA. Sir David Cuthbertson Medal Lecture. Energy metabolism in cancer and human immunodeficiency virus infection. Proc Nutr Soc 1997;56:763-75.
6. Barber MD, Ross JA, Fearon KC. Cancer cachexia. Surg Oncol 1999;8:133-41.
7. Tisdale MJ. Cancer anorexia and cachexia. Nutrition 2001;17:438-42.
8. Wigmore SJ, Todorov PT, Barber MD, et al. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor. Br J Surg 2000;87:53-8.
9. Ramos EJ, Suzuki S, Marks D, et al. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 2004;7:427-34.
10. Barber MD, Powell JJ, Lynch SF, et al. A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 2000;83:1443-7.
11. Ross JA, Fearon KC. Eicosanoid-dependent cancer cachexia and wasting. Curr Opin Clin Nutr Metab Care 2002;5:241-8.
12. Stroud MA. Peri-operative nutrition. In: Johnson C, Taylor I, eds. Advances in Surgery. London: Royal Society of Medicine Press, 2002:37-46.
13. Pascual Lopez A, Roquei Figuls M, Urrutia Cuchi G, et al. Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manage 2004;27:360-9.
14. Burns CP, Halabi S, Clamon G, et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer 2004;101:370-8.
15. Gordon JN, Trebble TM, Ellis RD, et al. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 2005;54:540-5.
16. Fanelli M, Sarmiento R, Gattuso D, et al. Thalidomide: a new anticancer drug? Expert Opin Investig Drugs 2003;12:1211-25.
17. Eleutherakis-Papaiakovou V, Bamias A, Dimopoulos MA. Thalidomide in cancer medicine. Ann Oncol 2004;15:1151-60.
18. Khan ZH, Simpson EJ, Cole AT, et al. Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass. Aliment Pharmacol Ther 2003;17:677-82.
19. Ruokonen E, Takala J. Dangers of growth hormone therapy in critically ill patients. Ann Med 2000;32:317-22.